Here, we will review recent reports on anti-VEGF efficacy in different clinical scenarios for the treatment of nonproliferative and proliferative diabetic retinopathy, compare anti-VEGF versus traditional DR therapies, and discuss the benefits of adjunctive combinations. Here, VEGFA is linked to proliferative diabetic retinopathy.